MAOB and Alzheimer disease: In this work, we demonstrated for the first time that DAN competitively inhibits MAO B with a micromolar Ki value for the human enzyme, showing, in addition, activity as an AChE inhibitor and hampering the aggregation of Aβ40 and PHF6, i.e., two probes of amyloid aggregation in AD brain.